戒烟后改用非可燃尼古丁或烟草制品与主要损害视力眼病的关联:全国性队列研究
OBJECTIVE: We assessed the risk of major vision-impairing eye diseases among smokers who quit combustible cigarettes (CC) and switch to noncombustible nicotine or tobacco products (NNTPs) compared with those who completely quit using tobacco. DESIGN: Retrospective cohort study.…
要点
- 与完全戒烟相比,改用NNTPs与主要损害视力眼病风险轻度但一致升高相关(SHR 1.07)。
- 糖尿病视网膜病变(SHR 1.24)和屈光与调节障碍(SHR 1.07)风险升高最明显。
- 从眼科角度,完全戒除所有尼古丁制品仍应是首选戒烟目标。
核心结论
- 与完全戒除尼古丁相比,从可燃卷烟改用非可燃尼古丁或烟草制品与主要损害视力眼病风险轻度但一致升高相关。
- 该发现挑战了用NNTPs替代可燃卷烟对视觉无害的假设,提示从眼科角度完全戒除所有尼古丁制品仍应是首选戒烟目标。
研究设计与样本
- 全国性纵向队列随访至多6年,使用标准化诊断代码识别新发主要损害视力眼病,并采用倾向评分匹配模拟伪随机比较。
- 采用Fine-Gray亚分布风险模型评估亚分布风险比(SHR),将全因死亡作为竞争风险。
主要发现
- 完全戒烟者和NNTP改用者的发病率分别为每1000人年41.1例和44.0例。
- 改用NNTPs与主要损害视力眼病风险升高相关(SHR 1.07;95%CI 1.02-1.13)。
- 糖尿病视网膜病变风险升高最明显(SHR 1.24;95%CI 1.00-1.53),屈光与调节障碍亦升高(SHR 1.07;95%CI 1.01-1.12)。
- 上述发现在逆概率加权和Cox比例风险模型中稳健,在敏感性分析和临床亚组中一致。
关键数值与推荐
- 主要结局为调整后SHR,比较NNTP改用者与完全戒烟者新发主要损害视力眼病的风险。
- 主要损害视力眼病包括白内障、青光眼、年龄相关性黄斑变性、糖尿病视网膜病变以及屈光和调节障碍。
临床怎么用
- 眼科医生应知晓,从可燃卷烟改用NNTPs并非视觉无害,完全戒除所有尼古丁制品仍是首选的戒烟目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We assessed the risk of major vision-impairing eye diseases among smokers who quit combustible cigarettes (CC) and switch to noncombustible nicotine or tobacco products (NNTPs) compared with those who completely quit using tobacco. DESIGN: Retrospective cohort study. PARTICIPANTS: About 179 273 adults from the Korean National Health Insurance Service who smoked CC in 2011 to 2012 and reported cessation in 2018 to 2019, classified into complete quitters and NNTP switchers. METHODS: This nationwide longitudinal cohort study followed participants for up to 6 years and identified incident major vision-impairing eye diseases (cataract, glaucoma, age-related macular degeneration, diabetic retinopathy, and refractive and accommodation disorders) using standardized diagnostic codes. Propensity score matching was applied to emulate a pseudo-randomized comparison, balanced on key demographic, clinical, comorbidity, and lifestyle characteristics. Subdistribution hazard ratios (SHRs) were evaluated using the Fine-Gray subdistribution hazards model accounting for all-cause mortality as a competing risk. MAIN OUTCOME MEASURES: Adjusted SHRs for incident major vision-impairing eye diseases. RESULTS: Among 32 316 matched participants followed for a mean of 4.6 years, 6328 incident major vision-impairing eye disease events occurred. The incidence was 41.1 and 44.0 per 1000 person-years for complete quitters and NNTP switchers, respectively. Switching to NNTPs was associated with an increased risk of major vision-impairing eye disease (SHR, 1.07; 95% CI, 1.02-1.13). The risk elevation was most pronounced for diabetic retinopathy (SHR, 1.24; 95% CI, 1.00-1.53) and refractive and accommodation disorders (SHR, 1.07; 95% CI, 1.01-1.12). These findings were robust across inverse probability-weighted and Cox proportional hazards models. The association remained consistent in sensitivity analyses and across clinical subgroups. CONCLUSIONS: Transitioning from CC to NNTPs is associated with a modest but consistent increase in the risk of major vision-impairing eye diseases compared with complete nicotine abstinence. These findings challenge the assumption that substituting NNTPs for CCs is visually harmless and indicate that, from an ophthalmic perspective, complete cessation of all nicotine products should remain the preferred cessation goal.
引用
- Cheon S, Kim Y, Kang ES, et al. Noncombustible Nicotine or Tobacco Product Use After Smoking Cessation and Major Vision-Impairing Diseases: A Nationwide Cohort Study. Am J Ophthalmol. 2026. PMID: 42288324. doi:10.1016/j.ajo.2026.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。